Creon After Pancreatic Surgery

Summary

This study will provide efficacy data for Creon 25000 MMS in PS patients as well as long-term safety data. During the long-term treatment with Creon 25000 nutritional parameters will be assessed and correlated with CFA

Timeline

Start

2008-04

Primary completion

2011-06

Completion

2011-06

Drugs

Indications